TACI, APRIL, and BR3 mRNA levels are increased in urine samples from SLE patients (36), and urinary Foxp3 mRNA levels can be used to assess LN severity and perform risk stratification (37). Here, FOXP3 is linked to systemic lupus erythematosus.